logo-loader

Immunoprecise Antibodies welcomes Champagne as advisory board member

Last updated: 12:59 21 Aug 2018 BST, First published: 07:59 21 Aug 2018 BST

1534852887_boardroom-610
Guy Champagne has now joined the advisory board at the firm

Immunoprecise Antibodies Ltd (CVE:IPA) told investors that Guy Champagne has resigned as director and will be joining the firm's advisory board with immediate effect.

The board thanked Mr Champagne for all of his efforts and looked forward to working with him as an advisory board member.

Immunoprecise is a therapeutic antibody discovery company.

Last month, shares rose after it revealed it was increasing capacity and reach, by launching its new cell facility in the Netherlands ahead of schedule due to demand.

The firm's current B-cell laboratory in British Columbia is operating at full capacity and booked out several months, it said, so the facility in the EU will speed up international growth, it had said.